Adage Capital Partners’s Takeda Pharmaceutical TAK Stock Holding History

Adage Capital Partners’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$119M	Buy	+6,424,984	New	+$113M	0.18%	106
2025 Q3	–	Sell	-2,533,725	Closed	-$39.2M	–	973
2025 Q2	$39.2M	Sell	2,533,725 -899,298	-26%	-$13.3M	0.07%	290
2025 Q1	$51M	Buy	+3,433,023	New	+$48.1M	0.09%	221
2021 Q3	–	Sell	-250,000	Closed	-$4.21M	–	1065
2021 Q2	$4.21M	Buy	+250,000	New	+$4.26M	0.01%	846
2019 Q2	–	Sell	-2,160,000	Closed	-$44M	–	760
2019 Q1	$44M	Buy	+2,160,000	New	+$43.5M	0.11%	217

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Adage Capital Partners's TAK Position: Q1 2026 in Review

Adage Capital Partners opened a new position in Takeda Pharmaceutical (TAK) in Q1 2026: 6,424,984 shares worth $119M. The stake represents 0.18% of the portfolio and ranks #106 among its holdings. This is a return to the name: Adage Capital Partners previously reported a position in TAK as recently as Q2 2025.

Adage Capital Partners first reported a position in TAK in Q1 2019 and has held it in 5 quarters since. 359 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Adage Capital Partners held 6,424,984 shares of Takeda Pharmaceutical worth $119M as of Q1 2026.
Takeda Pharmaceutical was a new Adage Capital Partners position in Q1 2026.
Takeda Pharmaceutical made up 0.18% of Adage Capital Partners's portfolio in Q1 2026, its #106 holding.
Adage Capital Partners first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 5 quarters since.
359 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.